Compile Data Set for Download or QSAR
Report error Found 254 for UniProtKB: O96020
LigandPNGBDBM50378304(CHEMBL568080)
Affinity DataIC50: 0.0300nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378288(CHEMBL567434)
Affinity DataIC50: 0.0300nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378289(CHEMBL565705)
Affinity DataIC50: 0.0400nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378290(CHEMBL568310)
Affinity DataIC50: 0.0400nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378291(CHEMBL568302)
Affinity DataIC50: 0.0400nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378319(CHEMBL568303)
Affinity DataIC50: 0.0400nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378305(CHEMBL583417)
Affinity DataIC50: 0.0400nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378292(CHEMBL566106)
Affinity DataIC50: 0.0500nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50003691(CHEMBL567624)
Affinity DataIC50: 0.0500nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378293(CHEMBL566550)
Affinity DataIC50: 0.0600nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378294(CHEMBL566972)
Affinity DataIC50: 0.0700nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378295(CHEMBL565490)
Affinity DataIC50: 0.0800nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378296(CHEMBL568510)
Affinity DataIC50: 0.0900nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378297(CHEMBL566105)
Affinity DataIC50: 0.0900nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378298(CHEMBL583421)
Affinity DataIC50: 0.0900nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378299(CHEMBL568079)
Affinity DataIC50: 0.0900nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378301(CHEMBL568311)
Affinity DataIC50: 0.100nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378302(CHEMBL583615)
Affinity DataIC50: 0.100nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378303(CHEMBL567208)
Affinity DataIC50: 0.100nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378212(CHEMBL575450)
Affinity DataIC50: 0.100nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378300(CHEMBL565930)
Affinity DataIC50: 0.100nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378307(CHEMBL566329)
Affinity DataIC50: 0.150nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378311(CHEMBL568301)
Affinity DataIC50: 0.200nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378312(CHEMBL578664)
Affinity DataIC50: 0.200nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378313(CHEMBL567626)
Affinity DataIC50: 0.200nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378314(CHEMBL578256)
Affinity DataIC50: 0.200nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378308(CHEMBL568509)
Affinity DataIC50: 0.200nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378309(CHEMBL568093)
Affinity DataIC50: 0.200nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378310(CHEMBL566971)
Affinity DataIC50: 0.200nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378315(CHEMBL578865)
Affinity DataIC50: 0.300nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378316(CHEMBL568291)
Affinity DataIC50: 0.300nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
TargetCDK2/Cyclin-E2(Human)
Pharmacosmos Holding

US Patent
LigandPNGBDBM601933(US11643416, Compound 1 | 4-((6'-hydroxy-8'-oxo-7',...)
Affinity DataIC50: 0.340nMAssay Description:Selected compounds disclosed herein were tested in kinase assays by Nanosyn (Santa Clara, CA) to determine their inhibitory effect on these CDKs. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

LigandPNGBDBM50378317(CHEMBL565273)
Affinity DataIC50: 0.400nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50378318(CHEMBL566539)
Affinity DataIC50: 0.400nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
TargetCDK2/Cyclin-E2(Human)
Pharmacosmos Holding

US Patent
LigandPNGBDBM601934(US11643416, Compound 2 | 4-((7'-oxo-7',8'-dihydro-...)
Affinity DataIC50: 0.5nMAssay Description:Selected compounds disclosed herein were tested in kinase assays by Nanosyn (Santa Clara, CA) to determine their inhibitory effect on these CDKs. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

LigandPNGBDBM7533(2,6,9-Trisubstituted purine deriv. 28 | (2R)-2-[[6...)
Affinity DataIC50: 0.520nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
TargetCDK2/Cyclin-E2(Human)
Pharmacosmos Holding

US Patent
LigandPNGBDBM601935(US11643416, Compound 3 | 4-((3'-oxo-2',3'-dihydro-...)
Affinity DataIC50: 0.560nMAssay Description:Selected compounds disclosed herein were tested in kinase assays by Nanosyn (Santa Clara, CA) to determine their inhibitory effect on these CDKs. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

LigandPNGBDBM50378306(CHEMBL567647)
Affinity DataIC50: 0.950nMAssay Description:Inhibition of Cdk2/cyclinEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
TargetCDK2/Cyclin-E2(Human)
Pharmacosmos Holding

US Patent
LigandPNGBDBM601942(US11643416, Compound 42 | 4-((8'-methyl-7'-oxo-7',...)
Affinity DataIC50: 1nMAssay Description:Selected compounds disclosed herein were tested in kinase assays by Nanosyn (Santa Clara, CA) to determine their inhibitory effect on these CDKs. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetCDK2/Cyclin-E2(Human)
Pharmacosmos Holding

US Patent
LigandPNGBDBM601953(US11643416, Compound 55 | 2'-((4-(piperazine-1- ca...)
Affinity DataIC50: 1nMAssay Description:Selected compounds disclosed herein were tested in kinase assays by Nanosyn (Santa Clara, CA) to determine their inhibitory effect on these CDKs. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetCDK2/Cyclin-E2(Human)
Pharmacosmos Holding

US Patent
LigandPNGBDBM601941(US11643416, Compound 23 | (S)-4-((6'-(fluoromethyl...)
Affinity DataIC50: 1nMAssay Description:Selected compounds disclosed herein were tested in kinase assays by Nanosyn (Santa Clara, CA) to determine their inhibitory effect on these CDKs. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetCDK2/Cyclin-E2(Human)
Pharmacosmos Holding

US Patent
LigandPNGBDBM601952(US11643416, Compound 54 | 2'-((4-(4-methylpiperazi...)
Affinity DataIC50: 1nMAssay Description:Selected compounds disclosed herein were tested in kinase assays by Nanosyn (Santa Clara, CA) to determine their inhibitory effect on these CDKs. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataIC50: 1nMAssay Description:Inhibition of CDK2/cyclin E (unknown origin) after 40 mins by scintillation counting analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2016
Entry Details Article
PubMed
TargetCDK2/Cyclin-E2(Human)
Pharmacosmos Holding

US Patent
LigandPNGBDBM601936(US11643416, Compound 4 | 4-((1'H-spiro[cyclohexane...)
Affinity DataIC50: 1nMAssay Description:Selected compounds disclosed herein were tested in kinase assays by Nanosyn (Santa Clara, CA) to determine their inhibitory effect on these CDKs. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetCDK2/Cyclin-E2(Human)
Pharmacosmos Holding

US Patent
LigandPNGBDBM601946(US11643416, Compound 46 | 4-((1',3'-dimethyl-1'H- ...)
Affinity DataIC50: 2nMAssay Description:Selected compounds disclosed herein were tested in kinase assays by Nanosyn (Santa Clara, CA) to determine their inhibitory effect on these CDKs. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

LigandPNGBDBM50299138((S)-1-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)pyrro...)
Affinity DataIC50: 2nMAssay Description:Inhibition of CDK2/Cyclin E after 60 mins by fluorescence electrophoresisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
LigandPNGBDBM50338873(N-(5-Amino-1-(4-methoxybenzyl)-1H-pyrazol-4-yl)-5-...)
Affinity DataIC50: 2.13nMAssay Description:Inhibition of CDK2/cyclin EMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/5/2013
Entry Details Article
PubMed
TargetCDK2/Cyclin-E2(Human)
Pharmacosmos Holding

US Patent
LigandPNGBDBM601938(US11643416, Compound 18 | (R)-4-((6'-(fluoromethyl...)
Affinity DataIC50: 2.70nMAssay Description:Selected compounds disclosed herein were tested in kinase assays by Nanosyn (Santa Clara, CA) to determine their inhibitory effect on these CDKs. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetCDK2/Cyclin-E2(Human)
Pharmacosmos Holding

US Patent
LigandPNGBDBM601954(US11643416, Compound 59 | 8'-methyl-2'-((4-((4-met...)
Affinity DataIC50: 3nMAssay Description:Selected compounds disclosed herein were tested in kinase assays by Nanosyn (Santa Clara, CA) to determine their inhibitory effect on these CDKs. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetCDK2/Cyclin-E2(Human)
Pharmacosmos Holding

US Patent
LigandPNGBDBM601940(US11643416, Compound 5 | 4-((1'-methyl-1'H-spiro[c...)
Affinity DataIC50: 3nMAssay Description:Selected compounds disclosed herein were tested in kinase assays by Nanosyn (Santa Clara, CA) to determine their inhibitory effect on these CDKs. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

Displayed 1 to 50 (of 254 total ) | Next | Last >>
Jump to: